ALLENTOWN, Pa. - Lehigh Valley Reilly Children’s Hospital said it is prepared to care for children with a syndrome linked to COVID-19.
Pediatric specialists at the hospital are monitoring the incidence of pediatric multisystem inflammatory syndrome regionally and internationally and are prepared to care for children with the illness, according to a Lehigh Valley Health Network news release.
The syndrome causes significant inflammation in organ systems, skin rashes and other symptoms. The syndrome appears to be connected to the coronavirus (COVID-19) and has affected children in numerous states, LVHN said.
While the syndrome is often compared to Kawasaki disease, it is thought to be a separate condition, LVHN said.
Standard treatment for the condition is steroid medication given to patients in conjunction with a commonly used IV medication used to treat inflammation in patients with an autoimmune disease.
“The majority of patients recover with no long-lasting effects and the percentage of children who die from the syndrome is very low,” said J. Nathan Hagstrom, MD, Chair, Department of Pediatrics.
Several children with PMIS have been treated in the pediatric intensive care unit and the pediatric inpatient unit at the Children’s Hospital and are recovering, according to LVHN.
A team of 10 pediatric specialists at Lehigh Valley Reilly Children’s Hospital is meeting daily to discuss care plans for the patients hospitalized with the syndrome, as well as to review the latest disease trends and treatments. The team includes Hagstrom, a pediatric infectious diseases specialist, two pediatric intensivists, two pediatric hospitalists, two pediatric cardiologists and two pediatric emergency medicine physicians.